Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.35
-0.03 (-0.56%)
Jun 22, 2026, 4:00 PM EDT - Market closed

Valneva SE Revenue

Valneva SE had revenue of 30.90M EUR in the quarter ending March 31, 2026, a decrease of -37.23%. This brings the company's revenue in the last twelve months to 156.33M, down -15.98% year-over-year. In the year 2025, Valneva SE had annual revenue of 174.66M with 3.00% growth.

Revenue (ttm)
156.33M EUR
Revenue Growth
-15.98%
P/S Ratio
2.78
Revenue / Employee
231,942 EUR
Employees
674
Market Cap
500.27M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025174.66M5.08M3.00%
Dec 31, 2024169.58M15.87M10.32%
Dec 31, 2023153.71M-207.59M-57.46%
Dec 31, 2022361.30M13.22M3.80%
Dec 31, 2021348.09M237.76M215.52%
Dec 31, 2020110.32M-15.88M-12.58%
Dec 31, 2019126.20M13.16M11.64%
Dec 31, 2018113.04M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sutro Biopharma99.61M
Arvinas89.40M
4D Molecular Therapeutics88.24M
Assembly Biosciences71.10M
XOMA Royalty48.56M
Neurogene925.00K
Altimmune36.00K
Revenue Rankings